S. Dunn

发表

FOXA1 Expression in Breast Cancer—Correlation with Luminal Subtype A and Survival

Charles M Perou, Dmitry Turbin, Harikrishna Nakshatri, 2007, Clinical Cancer Research.

Adverse association of expressed vascular endothelial growth factor (VEGF) with long-term outcome of stage I-III breast cancer (BrCa), with co-expression data of VEGF and Her2, Cox2, uPA and ER. Results from the British Columbia Tissue Microarray Project.

T. Nielsen, D. Huntsman, J. Ragaz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.

D. Huntsman, K. Gelmon, S. Dedhar, 2006, Current cancer drug targets.